Findings

What do systematic reviews say?

5 questions · 5 findings · 3 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 60%GRADE not reported 2 · 40%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Hyperbaric oxygen vs air breathing

Quality of life ‐ not reported · People undergoing radiotherapy for uterine cervical cancer

The review found no eligible studies for this question.

1 finding from 1 review

Hyperbaric oxygenation for tumour sensitisation to radiotherapy 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hyperbaric oxygen vs air breathing

Quality of life ‐ not reported · People with any one of a mixed group of cancers

The review found no eligible studies for this question.

1 finding from 1 review

Hyperbaric oxygenation for tumour sensitisation to radiotherapy 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hyperbaric oxygen vs air breathing to enhance the effectiveness of radiotherapy

Quality of life ‐ not reported · People undergoing radiation therapy for head and neck cancer

The review found no eligible studies for this question.

1 finding from 1 review

Hyperbaric oxygenation for tumour sensitisation to radiotherapy 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hyperbaric oxygen therapy (HBO) as an adjunct to conventional therapy vs conventional therapy

Quality of life · People with established (manifest) MRONJ

1 finding from 1 review

Interventions for managing medication‐related osteonecrosis of the jaw 2022 · Cochrane All outcomes
6 months
QoL measured with the Duke Health Profile; only within-group comparisons were provided; no score values, so a between-group analysis was not possible.
1 study
GRADE not reported

Hyperbaric oxygen therapy plus standard care (surgery, antibiotics, oral rinse) vs Standard care alone (surgery, antibiotics, oral rinse)

Quality of life · People with BRONJ (mean age ~66 years; most treated with bisphosphonates for cancer (multiple myeloma, breast cancer) or osteoporosis)

1 finding from 1 review

Interventions for treating bisphosphonate‐related osteonecrosis of the jaw (BRONJ) 2016 · Cochrane All outcomes
Baseline and 6 months
no estimate extracted
1 study · 49 participants
GRADE not reported